On May 19, the ART Lab joined colleagues from across UW–Madison for the 2026 Research Retreat of the Initiative for Theranostics and Particle Therapy (ITPT), an afternoon at the Health Sciences Learning Center dedicated to the science connecting radiopharmaceutical therapy, particle therapy, and everything in between. Four of us took the podium. In the main …
Hansel Comas-Rojas, staff radiochemist in the ART Lab, brought a new tracer to the field’s biggest stage this year. At the American Association for Cancer Research (AACR) 2026 Annual Meeting, he presented “Pilot [89Zr]Zr-LNTH-2403 PET Imaging in Healthy Non-Human Primates: Assessing Biodistribution, Dosimetry, Pharmacokinetics, and Safety.” In partnership with Lantheus , the study follows [89Zr]Zr-LNTH-2403 …
We’re thrilled to announce that Yadira Medina-Guevara has earned her Ph.D. After successfully defending her dissertation, “Advancing Targeted Radiopharmaceutical Therapy for Triple Negative Breast Cancer,” Yadira closes out a remarkable chapter in the ART Lab. Triple negative breast cancer remains one of the toughest cases in oncology, with few targeted options available to patients. Yadira’s …
This March, postdoctoral researcher Malick Bio Idrissou, Ph.D., headed to the 2026 PSMA & Beyond Conference to present some of the lab’s most exciting therapy work to date, supported by a trainee travel award for the meeting. In a talk titled “Next-Generation PSMA Therapy: [161Tb]Tb-ART-101 achieves superior tumor absorbed dose and anti-tumor efficacy in advanced …
Dr. Reinier Hernandez and Dr. Victor Santoro Fernandes have been awarded WARF Accelerator Phase 1 funding to advance TrackTGL, a novel PET-based cell tracking technology developed in the Department of Medical Physics. The award supports a focused translational effort to standardize and validate the technology in partnership with industry collaborators, positioning it for deployment in …
Malick Bio Idrissou, PhD, a postdoctoral researcher in the ART Lab has been selected to receive a $1,000 trainee travel grant for the 2026 PSMA & Beyond Conference, hosted by UCSF. Dr. Idrissou’s abstract has been accepted for poster presentation, and he has additionally been invited to deliver a two-minute “Power Pitch” oral presentation highlighting …
Victor Fernandes recently completed the National Science Foundation (NSF) I-Corps program, securing a $50,000 grant to explore the commercial translation of the lab’s in-vivo cell tracking technology. Over the course of the program, more than 150 customer discovery interviews were conducted with experts across academia, biotech, and industry to identify unmet needs and validate potential …
This October, four of our members (Malick, Yadira, Lauren, and Marcus (MJ)) were invited to give talks at the European Association of Nuclear Medicine 2025 Annual Congress. Across our entire lab, we had nine different presentations and opportunities to share our advances in radiopharmaceutical development and RPT radiobiology/toxicology.
The Hernandez Lab proudly celebrates the achievements of Yadira Medina and Nate Clemons, who both represented the group at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Annual Meeting. Yadira earned Third Place in the Poster Award for the Molecular Targeting Probes-Radioactive & Nonradioactive track for her work on the development of novel …